Zurich Cantonal Bank
MIRM icon

Zurich Cantonal Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Zurich Cantonal Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,815
Closed -$1.17M – 3125
2025
Q4 		$1.17M Buy
+14,815
New +$1.06M ﹤0.01% 1257

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Zurich Cantonal Bank's MIRM Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2026: 16,376 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #1192 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in MIRM as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in MIRM in Q1 2022 and has held it in 16 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Zurich Cantonal Bank held 16,376 shares of Mirum Pharmaceuticals worth $1.51M as of Q1 2026.
  • Mirum Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1192 holding.
  • Zurich Cantonal Bank first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.